Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions

15Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Apheresis can remove pathogens and mediators that contribute to pathogenic inflammatory responses in diseases not generally considered to be "Hematologic." Erythrocytapheresis can remove intracellular pathogens such as Babesiosis. Plasmapheresis can remove mediators of the inflammatory response in conditions such as sepsis, chronic autoimmune urticaria and malignant pertussis. Leukapheresis can remove potentially harmful leukocytes in Crohn's Disease and malignant pertussis. While apheresis can remove all of these substances, the clinical efficacy and pathophysiologic changes that occur during apheresis in these conditions are largely unknown. Hence, the clinical utility of apheresis in these conditions is largely unknown and research in these areas has the potential to benefit many patients with a variety of diseases.

References Powered by Scopus

Global trends in emerging infectious diseases

5745Citations
N/AReaders
Get full text

The clinical assessments treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America

1726Citations
N/AReaders
Get full text

Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003

1058Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Early therapeutic plasma exchange in septic shock: A prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers

118Citations
N/AReaders
Get full text

Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock

45Citations
N/AReaders
Get full text

Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study

45Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sloan, S. R., Andrzejewski, C., Aqui, N. A., Kiss, J. E., Krause, P. J., & Park, Y. A. (2015). Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions. Journal of Clinical Apheresis, 30(5), 259–264. https://doi.org/10.1002/jca.21370

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

50%

Researcher 5

28%

Professor / Associate Prof. 3

17%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

73%

Agricultural and Biological Sciences 2

13%

Chemical Engineering 1

7%

Computer Science 1

7%

Save time finding and organizing research with Mendeley

Sign up for free